186 related articles for article (PubMed ID: 27442255)
21. Risk of hepatocellular carcinoma after HCV eradication: Determining the role of portal hypertension by measuring spleen stiffness.
Dajti E; Marasco G; Ravaioli F; Colecchia L; Ferrarese A; Festi D; Colecchia A
JHEP Rep; 2021 Jun; 3(3):100289. PubMed ID: 34095798
[TBL] [Abstract][Full Text] [Related]
22. Different kinetics of liver stiffness using shear wave elastography in patients with chronic hepatitis C infection treated with interferon-free regimens.
Attia D; Deterding K; Cornberg J; Gebel MJ; Cornberg M; Manns MP; Wedemeyer H; Potthoff A
Eur J Gastroenterol Hepatol; 2019 Jan; 31(1):67-74. PubMed ID: 30239347
[TBL] [Abstract][Full Text] [Related]
23. Predicting Liver-Related Events Using Transient Elastography in Chronic Hepatitis C Patients with Sustained Virological Response.
Lee HW; Chon YE; Kim SU; Kim BK; Park JY; Kim DY; Ahn SH; Jung KS; Park YN; Han KH
Gut Liver; 2016 May; 10(3):429-36. PubMed ID: 26347515
[TBL] [Abstract][Full Text] [Related]
24. Dynamics of liver stiffness by transient elastography in patients with chronic hepatitis C virus infection receiving direct-acting antiviral therapy-Results from the German Hepatitis C-Registry.
Knop V; Mauss S; Goeser T; Geier A; Zimmermann T; Herzer K; Postel N; Friedrich-Rust M; Hofmann WP;
J Viral Hepat; 2020 Jul; 27(7):690-698. PubMed ID: 32096310
[TBL] [Abstract][Full Text] [Related]
25. Progression of liver stiffness predicts clinical events in HIV/HCV-coinfected patients with compensated cirrhosis.
Merchante N; Téllez F; Rivero-Juárez A; Ríos-Villegas MJ; Merino D; Márquez-Solero M; Omar M; Recio E; Pérez-Pérez M; Camacho Á; Macías-Dorado S; Macías J; Lorenzo-Moncada S; Rivero A; Pineda JA;
BMC Infect Dis; 2015 Dec; 15():557. PubMed ID: 26643257
[TBL] [Abstract][Full Text] [Related]
26. Liver stiffness measurement at complete virological response in hepatoma prediction for HBV-related cirrhosis patient with potent antiviral agent.
Wang JH; Hu TH; Chen CH; Hung CH; Yen YH; Chang KC; Lu SN
Kaohsiung J Med Sci; 2019 Nov; 35(11):708-714. PubMed ID: 31430035
[TBL] [Abstract][Full Text] [Related]
27. Liver stiffness and aspartate aminotransferase levels predict the risk for liver fibrosis progression in hepatitis C virus/HIV-coinfected patients.
Gonzalez FA; Van den Eynde E; Perez-Hoyos S; Navarro J; Curran A; Burgos J; Falcó V; Ocaña I; Ribera E; Crespo M
HIV Med; 2015 Apr; 16(4):211-8. PubMed ID: 25234826
[TBL] [Abstract][Full Text] [Related]
28. Reduction of liver stiffness by interferon treatment in the patients with chronic hepatitis C.
Arima Y; Kawabe N; Hashimoto S; Harata M; Nitta Y; Murao M; Nakano T; Shimazaki H; Kobayashi K; Ichino N; Osakabe K; Nishikawa T; Okumura A; Ishikawa T; Yoshioka K
Hepatol Res; 2010 Apr; 40(4):383-92. PubMed ID: 20236358
[TBL] [Abstract][Full Text] [Related]
29. Liver stiffness reduction correlates with histological characteristics of hepatitis C patients with sustained virological response.
Tachi Y; Hirai T; Kojima Y; Ishizu Y; Honda T; Kuzuya T; Hayashi K; Ishigami M; Goto H
Liver Int; 2018 Jan; 38(1):59-67. PubMed ID: 28557143
[TBL] [Abstract][Full Text] [Related]
30. Regression of liver stiffness after sustained hepatitis C virus (HCV) virological responses among HIV/HCV-coinfected patients.
ANRS CO13 HEPAVIH Cohort
AIDS; 2015 Sep; 29(14):1821-30. PubMed ID: 26372388
[TBL] [Abstract][Full Text] [Related]
31. Longitudinal liver stiffness assessment in patients with chronic hepatitis C undergoing antiviral therapy.
Martinez SM; Foucher J; Combis JM; Métivier S; Brunetto M; Capron D; Bourlière M; Bronowicki JP; Dao T; Maynard-Muet M; Lucidarme D; Merrouche W; Forns X; de Lédinghen V
PLoS One; 2012; 7(10):e47715. PubMed ID: 23082200
[TBL] [Abstract][Full Text] [Related]
32. Noninvasive Assessment of Liver Fibrosis By Transient Elastography and FIB4/APRI for Prediction of Treatment Response in Chronic Hepatitis C-An Experience from a Tertiary Care Hospital.
Taneja S; Tohra S; Duseja A; Dhiman RK; Chawla YK
J Clin Exp Hepatol; 2016 Dec; 6(4):282-290. PubMed ID: 28003717
[TBL] [Abstract][Full Text] [Related]
33. Association between Liver Stiffness and Liver-Related Events in HCV-Infected Patients after Successful Treatment with Direct-Acting Antivirals.
Rodprasert N; Hongboontry T; Cherdchoochart C; Chaiteerakij R
Medicina (Kaunas); 2023 Mar; 59(3):. PubMed ID: 36984603
[No Abstract] [Full Text] [Related]
34. Liver Stiffness at the Time of Sustained Virological Response Predicts the Clinical Outcome in People Living With Human Immunodeficiency Virus and Hepatitis C Virus With Advanced Fibrosis Treated With Direct-acting Antivirals.
Corma-Gómez A; Macías J; Téllez F; Freyre-Carrillo C; Morano L; Rivero-Juárez A; Ríos MJ; Alados JC; Vera-Méndez FJ; Merchante N; Palacios R; Granados R; Merino D; De Los Santos I; Pineda JA
Clin Infect Dis; 2020 Dec; 71(9):2354-2362. PubMed ID: 31754695
[TBL] [Abstract][Full Text] [Related]
35. Progression of liver fibrosis in HIV/hepatitis C virus-coinfected individuals on antiretroviral therapy with early stages of liver fibrosis at baseline.
Sanmartín R; Tor J; Sanvisens A; López JJ; Jou A; Muga R; Ojanguren I; Barluenga E; Videla S; Planas R; Clotet B; Tural C
HIV Med; 2014 Apr; 15(4):203-12. PubMed ID: 24245909
[TBL] [Abstract][Full Text] [Related]
36. Fibroscan liver stiffness after anti-viral treatment for hepatitis C is independently associated with adverse outcomes.
Vutien P; Kim NJ; Moon AM; Pearson M; Su F; Berry K; Gelman H; Ioannou GN
Aliment Pharmacol Ther; 2020 Dec; 52(11-12):1717-1727. PubMed ID: 32951216
[TBL] [Abstract][Full Text] [Related]
37. Diabetes influences liver stiffness in chronic hepatitis C patients with and without virological cure: A longitudinal study.
Pontual DM; Nabuco LC; Luiz RR; Cardoso AC; Perez RM; Villela-Nogueira CA
Clinics (Sao Paulo); 2021; 76():e3236. PubMed ID: 34755761
[TBL] [Abstract][Full Text] [Related]
38. Low incidence of HCC in chronic hepatitis C patients with pretreatment liver stiffness measurements below 17.5 kilopascal who achieve SVR following DAAs.
Søholm J; Hansen JF; Mössner B; Røge BT; Lauersen A; Hansen JB; Weis N; Barfod TS; Lunding S; Øvrehus A; Mohey R; Thielsen P; Christensen PB
PLoS One; 2020; 15(12):e0243725. PubMed ID: 33301499
[TBL] [Abstract][Full Text] [Related]
39. Non-invasive assessment of fibrosis regression and portal hypertension in patients with advanced chronic hepatitis C virus (HCV)-associated liver disease and sustained virologic response (SVR): 3 years follow-up of a prospective longitudinal study.
Knop V; Hoppe D; Vermehren J; Troetschler S; Herrmann E; Vermehren A; Friedrich-Rust M; Sarrazin C; Trebicka J; Zeuzem S; Welker MW
J Viral Hepat; 2021 Nov; 28(11):1604-1613. PubMed ID: 34342081
[TBL] [Abstract][Full Text] [Related]
40. Liver stiffness predicts the response to direct-acting antiviral-based therapy against chronic hepatitis C in cirrhotic patients.
Neukam K; Morano-Amado LE; Rivero-Juárez A; Macías J; Granados R; Romero-Palacios A; Márquez M; Merino D; Ortega E; Alados-Arboledas JC; Cucurull J; Omar M; Ryan-Murua P; Pineda JA;
Eur J Clin Microbiol Infect Dis; 2017 May; 36(5):853-861. PubMed ID: 28004322
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
